Physician profile
James P Rough
NPI 1497082234
$1,255.51
in general payments reported to CMS, 2019-2025
11 companies · $22.71 in 2025
The $22.71 reported for 2025 was less than what a typical Plastic Surgery provider received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $459 · 2020: $73.48 · 2021: $139 · 2022: $49.82 · 2023: $28.49 · 2024: $483 · 2025: $22.71.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $534.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $534.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mentor Worldwide LLC | $641.06 | 2019-2024 | Mentor Memorygel Resterilizable Gel Sizer |
| Abbvie INC. | $150.00 | 2024 | |
| Musculoskeletal Transplant Foundation INC. | $110.91 | 2021 | |
| Amgen INC. | $85.48 | 2019 | |
| Galderma Laboratories, L.P. | $82.19 | 2019-2024 | |
| Allergan, INC. | $50.57 | 2021-2022 | |
| Revance Therapeutics, INC. | $44.19 | 2024-2025 | Daxxify |
| Pacira Pharmaceuticals Incorporated | $39.02 | 2019 | |
| Apyx Medical Corporation | $24.86 | 2019-2020 | |
| Tei Biosciences INC | $14.19 | 2019 | |
| Integra Lifesciences Corporation | $13.04 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Rough listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.